Candriam S.C.A. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,206,414
-11.1%
313,2620.0%0.04%
-11.9%
Q2 2023$5,857,999
+5.0%
313,262
-5.2%
0.04%
+7.7%
Q1 2023$5,580,396
-10.0%
330,399
+5.5%
0.04%
-7.1%
Q4 2022$6,202,297
-17.7%
313,2620.0%0.04%
-20.8%
Q3 2022$7,537,000
+56.2%
313,262
+18.5%
0.05%
+32.5%
Q2 2022$4,825,000
+39.1%
264,385
+67.6%
0.04%
+66.7%
Q1 2022$3,469,000157,7640.02%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders